Cargando…

Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective)

OBJECTIVE: The aim of the study was to explore experiences from the next of kin’s perspective of a new involvement method in the regulatory investigation process of adverse events causing patient death. METHODS: The study design was a qualitative process evaluation of the new involvement method in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiig, Siri, Haraldseid-Driftland, Cecilie, Tvete Zachrisen, Rannveig, Hannisdal, Einar, Schibevaag, Lene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612916/
https://www.ncbi.nlm.nih.gov/pubmed/31651540
http://dx.doi.org/10.1097/PTS.0000000000000630
_version_ 1784603539461373952
author Wiig, Siri
Haraldseid-Driftland, Cecilie
Tvete Zachrisen, Rannveig
Hannisdal, Einar
Schibevaag, Lene
author_facet Wiig, Siri
Haraldseid-Driftland, Cecilie
Tvete Zachrisen, Rannveig
Hannisdal, Einar
Schibevaag, Lene
author_sort Wiig, Siri
collection PubMed
description OBJECTIVE: The aim of the study was to explore experiences from the next of kin’s perspective of a new involvement method in the regulatory investigation process of adverse events causing patient death. METHODS: The study design was a qualitative process evaluation of the new involvement method in two Norwegian counties. Next of kin who had lost a close family member in an adverse event were invited to a 2-hour face-to-face meeting with regulatory inspectors to shed light on the event from the next of kin’s perspective. Data collection involved 18 interviews with 29 next of kin who had participated in the meeting and observations (20 hours) of meetings from 2017 to 2018. Data were analyzed using a thematic content analysis. RESULTS: Next of kin wanted to be involved and had in-depth knowledge about the adverse event and the healthcare system. Their involvement extended beyond sharing information, and some experienced it as having a therapeutic effect and contributing to transparency and trust building. The inspectors’ professional, social, and human skills determined the experiences of the involvement and were key for next of kin’s positive experiences. The meeting was emotionally challenging, and some next of kin found it difficult to understand the regulators’ independent role and suggested improving information given to the next of kin before the meeting. CONCLUSIONS: Although the meeting was emotionally challenging, the next of kin had a positive experience of being involved in the investigation and believed that their information contributed to improving the investigation process.
format Online
Article
Text
id pubmed-8612916
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86129162021-11-29 Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective) Wiig, Siri Haraldseid-Driftland, Cecilie Tvete Zachrisen, Rannveig Hannisdal, Einar Schibevaag, Lene J Patient Saf Original Studies OBJECTIVE: The aim of the study was to explore experiences from the next of kin’s perspective of a new involvement method in the regulatory investigation process of adverse events causing patient death. METHODS: The study design was a qualitative process evaluation of the new involvement method in two Norwegian counties. Next of kin who had lost a close family member in an adverse event were invited to a 2-hour face-to-face meeting with regulatory inspectors to shed light on the event from the next of kin’s perspective. Data collection involved 18 interviews with 29 next of kin who had participated in the meeting and observations (20 hours) of meetings from 2017 to 2018. Data were analyzed using a thematic content analysis. RESULTS: Next of kin wanted to be involved and had in-depth knowledge about the adverse event and the healthcare system. Their involvement extended beyond sharing information, and some experienced it as having a therapeutic effect and contributing to transparency and trust building. The inspectors’ professional, social, and human skills determined the experiences of the involvement and were key for next of kin’s positive experiences. The meeting was emotionally challenging, and some next of kin found it difficult to understand the regulators’ independent role and suggested improving information given to the next of kin before the meeting. CONCLUSIONS: Although the meeting was emotionally challenging, the next of kin had a positive experience of being involved in the investigation and believed that their information contributed to improving the investigation process. Lippincott Williams & Wilkins 2021-12 2019-10-24 /pmc/articles/PMC8612916/ /pubmed/31651540 http://dx.doi.org/10.1097/PTS.0000000000000630 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Studies
Wiig, Siri
Haraldseid-Driftland, Cecilie
Tvete Zachrisen, Rannveig
Hannisdal, Einar
Schibevaag, Lene
Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective)
title Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective)
title_full Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective)
title_fullStr Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective)
title_full_unstemmed Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective)
title_short Next of Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part I – The Next of Kin’s Perspective)
title_sort next of kin involvement in regulatory investigations of adverse events that caused patient death: a process evaluation (part i – the next of kin’s perspective)
topic Original Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612916/
https://www.ncbi.nlm.nih.gov/pubmed/31651540
http://dx.doi.org/10.1097/PTS.0000000000000630
work_keys_str_mv AT wiigsiri nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartithenextofkinsperspective
AT haraldseiddriftlandcecilie nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartithenextofkinsperspective
AT tvetezachrisenrannveig nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartithenextofkinsperspective
AT hannisdaleinar nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartithenextofkinsperspective
AT schibevaaglene nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartithenextofkinsperspective